159 related articles for article (PubMed ID: 30797866)
1. Single-domain antibody fusion proteins can target and shuttle functional proteins into macrophage mannose receptor expressing macrophages.
De Vlaeminck Y; Lecocq Q; Giron P; Heirman C; Geeraerts X; Bolli E; Movahedi K; Massa S; Schoonooghe S; Thielemans K; Goyvaerts C; Van Ginderachter JA; Breckpot K
J Control Release; 2019 Apr; 299():107-120. PubMed ID: 30797866
[TBL] [Abstract][Full Text] [Related]
2. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments.
Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V
J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306
[TBL] [Abstract][Full Text] [Related]
3. Clinical Translation of [
Xavier C; Blykers A; Laoui D; Bolli E; Vaneyken I; Bridoux J; Baudhuin H; Raes G; Everaert H; Movahedi K; Van Ginderachter JA; Devoogdt N; Caveliers V; Lahoutte T; Keyaerts M
Mol Imaging Biol; 2019 Oct; 21(5):898-906. PubMed ID: 30671739
[TBL] [Abstract][Full Text] [Related]
4. Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages.
Movahedi K; Schoonooghe S; Laoui D; Houbracken I; Waelput W; Breckpot K; Bouwens L; Lahoutte T; De Baetselier P; Raes G; Devoogdt N; Van Ginderachter JA
Cancer Res; 2012 Aug; 72(16):4165-77. PubMed ID: 22719068
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of [
Bala G; Baudhuin H; Remory I; Gillis K; Debie P; Krasniqi A; Lahoutte T; Raes G; Devoogdt N; Cosyns B; Hernot S
Mol Imaging Biol; 2018 Apr; 20(2):260-267. PubMed ID: 28875290
[TBL] [Abstract][Full Text] [Related]
6. Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages.
Ye J; Yang Y; Dong W; Gao Y; Meng Y; Wang H; Li L; Jin J; Ji M; Xia X; Chen X; Jin Y; Liu Y
Int J Nanomedicine; 2019; 14():3203-3220. PubMed ID: 31118632
[No Abstract] [Full Text] [Related]
7. SPECT imaging of joint inflammation with Nanobodies targeting the macrophage mannose receptor in a mouse model for rheumatoid arthritis.
Put S; Schoonooghe S; Devoogdt N; Schurgers E; Avau A; Mitera T; D'Huyvetter M; De Baetselier P; Raes G; Lahoutte T; Matthys P
J Nucl Med; 2013 May; 54(5):807-14. PubMed ID: 23447654
[TBL] [Abstract][Full Text] [Related]
8. Exploiting Manipulated Small Extracellular Vesicles to Subvert Immunosuppression at the Tumor Microenvironment through Mannose Receptor/CD206 Targeting.
Fiani ML; Barreca V; Sargiacomo M; Ferrantelli F; Manfredi F; Federico M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878276
[TBL] [Abstract][Full Text] [Related]
9. Mannose receptor (MR) engagement by mesothelin GPI anchor polarizes tumor-associated macrophages and is blocked by anti-MR human recombinant antibody.
Dangaj D; Abbott KL; Mookerjee A; Zhao A; Kirby PS; Sandaltzopoulos R; Powell DJ; Lamazière A; Siegel DL; Wolf C; Scholler N
PLoS One; 2011; 6(12):e28386. PubMed ID: 22163010
[TBL] [Abstract][Full Text] [Related]
10. Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targeting.
Erreni M; D'Autilia F; Avigni R; Bolli E; Arnouk SM; Movahedi K; Debie P; Anselmo A; Parente R; Vincke C; van Leeuwen FWB; Allavena P; Garlanda C; Mantovani A; Doni A; Hernot S; Van Ginderachter JA
Theranostics; 2023; 13(1):355-373. PubMed ID: 36593955
[No Abstract] [Full Text] [Related]
11. Macrophage mannose receptor-specific gene delivery vehicle for macrophage engineering.
Ruan GX; Chen YZ; Yao XL; Du A; Tang GP; Shen YQ; Tabata Y; Gao JQ
Acta Biomater; 2014 May; 10(5):1847-55. PubMed ID: 24440421
[TBL] [Abstract][Full Text] [Related]
12. Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors.
Bolli E; D'Huyvetter M; Murgaski A; Berus D; Stangé G; Clappaert EJ; Arnouk S; Pombo Antunes AR; Krasniqi A; Lahoutte T; Gonçalves A; Vuylsteke M; Raes G; Devoogdt N; Movahedi K; Van Ginderachter JA
J Control Release; 2019 Nov; 314():1-11. PubMed ID: 31626860
[TBL] [Abstract][Full Text] [Related]
13. Targeting Protumoral Tumor-Associated Macrophages with Nanobody-Functionalized Nanogels through Strain Promoted Azide Alkyne Cycloaddition Ligation.
Nuhn L; Bolli E; Massa S; Vandenberghe I; Movahedi K; Devreese B; Van Ginderachter JA; De Geest BG
Bioconjug Chem; 2018 Jul; 29(7):2394-2405. PubMed ID: 29889515
[TBL] [Abstract][Full Text] [Related]
14. Molecular imaging of tumor-infiltrating macrophages in a preclinical mouse model of breast cancer.
Sun X; Gao D; Gao L; Zhang C; Yu X; Jia B; Wang F; Liu Z
Theranostics; 2015; 5(6):597-608. PubMed ID: 25825599
[TBL] [Abstract][Full Text] [Related]
15. Biotherapeutic target or sink: analysis of the macrophage mannose receptor tissue distribution in murine models of lysosomal storage diseases.
Zhang XS; Brondyk W; Lydon JT; Thurberg BL; Piepenhagen PA
J Inherit Metab Dis; 2011 Jun; 34(3):795-809. PubMed ID: 21416197
[TBL] [Abstract][Full Text] [Related]
16. The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy.
Du H; Levine M; Ganesa C; Witte DP; Cole ES; Grabowski GA
Am J Hum Genet; 2005 Dec; 77(6):1061-74. PubMed ID: 16380916
[TBL] [Abstract][Full Text] [Related]
17. Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide.
Scodeller P; Simón-Gracia L; Kopanchuk S; Tobi A; Kilk K; Säälik P; Kurm K; Squadrito ML; Kotamraju VR; Rinken A; De Palma M; Ruoslahti E; Teesalu T
Sci Rep; 2017 Nov; 7(1):14655. PubMed ID: 29116108
[TBL] [Abstract][Full Text] [Related]
18. The function of cancer-shed gangliosides in macrophage phenotype: involvement with angiogenesis.
Chung TW; Choi HJ; Park MJ; Choi HJ; Lee SO; Kim KJ; Kim CH; Hong C; Kim KH; Joo M; Ha KT
Oncotarget; 2017 Jan; 8(3):4436-4448. PubMed ID: 28032600
[TBL] [Abstract][Full Text] [Related]
19. Diverse in vivo effects of soluble and membrane-bound M-CSF on tumor-associated macrophages in lymphoma xenograft model.
Liao J; Feng W; Wang R; Ma S; Wang L; Yang X; Yang F; Lin Y; Ren Q; Zheng G
Oncotarget; 2016 Jan; 7(2):1354-66. PubMed ID: 26595525
[TBL] [Abstract][Full Text] [Related]
20. Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles.
Zhu S; Niu M; O'Mary H; Cui Z
Mol Pharm; 2013 Sep; 10(9):3525-30. PubMed ID: 23901887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
